Raman Mehrzad1, Michiya Nishino2, James Connolly2, Helen Wang2, Peter Mowschenson1, Per-Olof Hasselgren3. 1. Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 2. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 3. Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: phasselg@bidmc.harvard.edu.
Abstract
BACKGROUND: Reports suggest that the incidence of tumors diagnosed as follicular variant of papillary thyroid cancer (FVPTC) is increasing and that this increase may reflect changes in diagnostic criteria with tumors presently being diagnosed as FVPTC previously being defined as follicular lesions, in particular follicular adenomas. Changes during recent years in the relationship between the incidence of FVPTC and follicular adenomas have not been reported. Herein, we have compared changes in the incidence of FVPTC with changes in the incidence of follicular adenomas. METHODS: The study is a retrospective analysis of a prospective database of patients undergoing thyroid surgery between January 1, 2004, and December 31, 2013. RESULTS: A total of 953 thyroid procedures performed in 851 patients were reviewed. The incidence of FVPTC increased approximately 4-fold during the study period when expressed as percentage of all thyroidectomies with the increase mainly reflecting an increase in the incidence of noninvasive FVPTC. The incidence of follicular adenomas decreased in a reverse fashion resulting in a >10-fold increase in the ratio between FVPTC and follicular adenomas during the study period. CONCLUSION: Although the present results suggest that some tumors previously diagnosed as follicular adenomas are increasingly classified as FVPTC, in particular noninvasive FVPTC, the possibility that the results at least in part also reflect a true increase in the incidence of FVPTC cannot be ruled out. If the increased incidence of FVPTC reflects a lowered threshold for the diagnosis of FVPTC it is possible that some tumors presently being classified as FVPTC are overdiagnosed as cancer and may currently be treated more aggressively than needed.
BACKGROUND: Reports suggest that the incidence of tumors diagnosed as follicular variant of papillary thyroid cancer (FVPTC) is increasing and that this increase may reflect changes in diagnostic criteria with tumors presently being diagnosed as FVPTC previously being defined as follicular lesions, in particular follicular adenomas. Changes during recent years in the relationship between the incidence of FVPTC and follicular adenomas have not been reported. Herein, we have compared changes in the incidence of FVPTC with changes in the incidence of follicular adenomas. METHODS: The study is a retrospective analysis of a prospective database of patients undergoing thyroid surgery between January 1, 2004, and December 31, 2013. RESULTS: A total of 953 thyroid procedures performed in 851 patients were reviewed. The incidence of FVPTC increased approximately 4-fold during the study period when expressed as percentage of all thyroidectomies with the increase mainly reflecting an increase in the incidence of noninvasive FVPTC. The incidence of follicular adenomas decreased in a reverse fashion resulting in a >10-fold increase in the ratio between FVPTC and follicular adenomas during the study period. CONCLUSION: Although the present results suggest that some tumors previously diagnosed as follicular adenomas are increasingly classified as FVPTC, in particular noninvasive FVPTC, the possibility that the results at least in part also reflect a true increase in the incidence of FVPTC cannot be ruled out. If the increased incidence of FVPTC reflects a lowered threshold for the diagnosis of FVPTC it is possible that some tumors presently being classified as FVPTC are overdiagnosed as cancer and may currently be treated more aggressively than needed.
Authors: Miguel Paja; Carles Zafón; Carmela Iglesias; Aitziber Ugalde; Jose Manuel Cameselle-Teijeiro; Gemma Rodríguez-Carnero; Pilar Fernández-Seara; Emma Anda; Antónia Povoa; Hernán Quiceno; Nancy M Sánchez-Gómez; Clarisa González; Luis García-Pascual; Inés Gómez de la Riva; Concha Blanco; Telma Meizoso; Garcilaso Riesco-Eizaguirre; Ismael Capel; María Victoria Ortega; Isabel Mancha; Montserrat Chao; Victoria Alcázar; Esther Roselló; Javier Maravall; Susana López-Agulló; Antonia Pérez-Lázaro; Pascual Meseguer; Javier Sanz; Jose J Paricio; Saioa Echeverría; Ángel Castaño; Rosa M Bella Journal: Endocrine Date: 2021-01-23 Impact factor: 3.633
Authors: Zviadi Aburjania; Samuel Jang; Celina Montemayor-Garcia; Ricardo V Lloyd; David F Schneider; Rebecca S Sippel; Herbert Chen; Dawn M Elfenbein Journal: J Surg Res Date: 2017-05-04 Impact factor: 2.192
Authors: Raman Mehrzad; Michiya Nishino; Carmelo Nucera; Dora Dias-Santagata; James V Hennessey; Per-Olof Hasselgren Journal: Int J Surg Case Rep Date: 2017-07-20